title: [The value of CEA in post-therapeutic monitoring of head and neck carcinoma].
authors.forename: R
authors.initials: R
authors.lastname: Fiorella
authors.forename: V
authors.initials: V
authors.lastname: Di Nicola
authors.forename: C
authors.initials: C
authors.lastname: Giannubilo
authors.forename: M
authors.initials: M
authors.lastname: Facondo
mesh_terms: D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D007012:Hypopharyngeal Neoplasms / Q000276:immunology* / Q000601:surgery; D007822:Laryngeal Neoplasms / Q000276:immunology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000276:immunology* / Q000601:surgery; D010610:Pharyngeal Neoplasms / Q000276:immunology*; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D002272:Carcinoembryonic Antigen
vernacular_title: Il valore del CEA nel monitoraggio post-terapeutico dei carcinomi delle VADS.